Stock 4579 RAQUALIA PHARMA INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus RaQualia Pharma Inc.

Equities

4579

JP3967150008

Delayed Japan Exchange
Other stock markets
 02:00:00 2024-07-16 am EDT 		5-day change 1st Jan Change
638 JPY +2.90% Intraday chart for RaQualia Pharma Inc. +6.33% -7.27%
Mar. 26 RaQualia Pharma Inc. completed the acquisition of FIMECS, Inc. from Yusuke Tominari, Kamakanae, Nissay Capital No. 11 Investment Limited Partnership managed by Nissay Capital Co., Ltd., ANRI No. 4 Fund managed by ANRI and others. CI
Feb. 14 RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2024 CI

Evolution of the average Target Price on RaQualia Pharma Inc.

Price target over the last 5 years

History of analyst recommendation changes

a.ACRFckVzaVmaUP6QOiWHQro1YNh-mrufaMSZrT5sRzE.MR1xMQBAHinbaYunD0-_JdABD-ANz97lAaHt2Us9CFJEESo2LRAZNPk0yg~490e7ae555eb1e8f963abcff6a7e2425

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
620 JPY
Average target price
1,800 JPY
Spread / Average Target
+190.32%
High Price Target
1,800 JPY
Spread / Highest target
+190.32%
Low Price Target
1,800 JPY
Spread / Lowest Target
+190.32%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 4579 Stock
  4. Consensus RaQualia Pharma Inc.